Tuesday, 26 March 2019

Questions (853, 929)

Thomas P. Broughan

Question:

853. Deputy Thomas P. Broughan asked the Minister for Health if patient advocacy groups will be included in the terms of reference for the mini-review by his Department of the drugs approval process here; and if he will make a statement on the matter. [13700/19]

View answer

Michael Healy-Rae

Question:

929. Deputy Michael Healy-Rae asked the Minister for Health if patient groups (details supplied) will be included in the review of the drug approval process here; and if he will make a statement on the matter. [14108/19]

View answer

Written answers (Question to Health)

I propose to take Questions Nos. 853 and 929 together.

My Department has completed a tender process for a review of the HSE reimbursement and pricing decision-making process and are currently appointing a consultancy firm to complete this review.

Although patients groups were not included in the terms of reference, consideration will be given to consultation with relevant stakeholders.